A trial result describes the people and setting studied. Applying it elsewhere requires checking the differences that could change benefit or harm.
A primary methodological framework used trial-participation propensity scores to assess similarity between trial participants and a target population. Its worked example was outside oncology; it provides a way to examine generalizability, not a validated cancer-treatment matching rule. Weighting measured characteristics depends on assumptions and sufficient overlap. Disease, treatment setting, prior therapy and other possible effect modifiers still matter, and an average trial effect is not an individual forecast.
Shares Confounding by indication, Evidence from measurement to patient benefit.
Shares External validation, Evidence from measurement to patient benefit.
Shares Subgroup analysis (forest plots), Evidence from measurement to patient benefit.
Shares External validation, Evidence from measurement to patient benefit.
Shares External validation, Evidence from measurement to patient benefit.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/